Company Valuation: Novacyt

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2024 2025 2026 2027
Market Cap 1 309.3 86.78 42.47 27.57 32.77 -
Change - -71.94% - -35.08% 18.86% -
Enterprise Value (EV) 1 190.3 86.78 42.47 17.5 34.73 37.61
Change - -54.41% - -58.79% 98.43% 8.31%
P/E - -3.01x -0.87x - - -
PBR - - - - - -
PEG - - - - - -
Capitalization / Revenue 2.72x - - 1.19x 1.07x 0.94x
EV / Revenue 1.67x - - 0.75x 1.14x 1.08x
EV / EBITDA 4.32x - - -1.94x -5.05x -13.8x
EV / EBIT 4.57x - - -1.33x -3.47x -7.13x
EV / FCF - - - -1.59x -3.88x -8.68x
FCF Yield - - - -62.7% -25.8% -11.5%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 - -0.408 -0.6934 - - -
Distribution rate - - - - - -
Net sales 1 113.8 - - 23.18 30.52 34.86
EBITDA 1 44.06 - - -9.014 -6.878 -2.727
EBIT 1 41.68 - - -13.13 -10 -5.273
Net income - -29.16 -49.07 - - -
Net Debt 1 -119 - - -10.07 1.956 4.842
Reference price 2 4.3800 1.2295 0.6020 0.3910 0.4520 0.4520
Nbr of stocks (in thousands) 70,616 70,582 70,547 70,511 72,502 -
Announcement Date 4/28/22 A 4/27/23 A 4/30/25 A 4/30/26 A - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- 1.14x-5.05x - 36.65M
18.07x6.54x12.9x1.78% 65.28B
30.04x7.96x26.09x0.05% 54.57B
36.97x6.56x19.6x0.88% 53.59B
34.86x3.39x14.64x-.--% 45.03B
48.82x5.62x30.9x-.--% 42.17B
-19.09x184.46x-20.29x-.--% 39.42B
28.28x8.04x20.81x0.38% 32.71B
27.72x5.84x15.15x-.--% 24.01B
36.39x6.61x22.07x-.--% 26.5B
Average 26.90x 23.62x 13.68x 0.34% 38.33B
Weighted average by Cap. 26.69x 24.66x 15.93x 0.46%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Novacyt

Historical PBR trend

Valuation ratios - PBR - Novacyt

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Novacyt

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Novacyt